Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedFeb 01, 2023
DataAggregated Company Financials
Companies7
  • 7D9.8%
  • 3M14.4%
  • 1Y13.0%
  • YTD2.8%

Over the last 7 days, the Life Sciences industry has remained flat. As for the the longer term, the industry is up 5.5% over the past 12 months. As for the next few years, earnings are expected to grow by 119% per annum.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Feb 2023NT$49.8bNT$2.7bNT$85.3m19.3x583.6x18.6x
Fri, 30 Dec 2022NT$50.0bNT$2.7bNT$85.3m18.8x586.4x18.7x
Sun, 27 Nov 2022NT$51.3bNT$2.7bNT$139.5m18.5x367.9x19.2x
Tue, 25 Oct 2022NT$43.7bNT$3.0bNT$482.8m23.1x90.5x14.6x
Thu, 22 Sep 2022NT$45.6bNT$3.0bNT$482.8m25.6x94.4x15.2x
Sat, 20 Aug 2022NT$41.7bNT$3.0bNT$498.3m25.2x83.6x13.7x
Mon, 18 Jul 2022NT$38.5bNT$3.1bNT$325.1m37.3x118.3x12.5x
Wed, 15 Jun 2022NT$40.7bNT$3.1bNT$325.1m36.6x125.2x13.3x
Fri, 13 May 2022NT$28.8bNT$2.9bNT$80.8m27.4x356.8x9.8x
Sun, 10 Apr 2022NT$34.8bNT$3.2bNT$164.4m27.6x211.4x10.9x
Tue, 08 Mar 2022NT$34.2bNT$3.0b-NT$120,147,000.0034.9x-284.4x11.2x
Thu, 03 Feb 2022NT$35.8bNT$3.0b-NT$120,147,000.0034.3x-298.1x11.8x
Sat, 01 Jan 2022NT$39.0bNT$3.0b-NT$120,147,000.0037.6x-324.4x12.8x
Mon, 29 Nov 2021NT$38.5bNT$3.0b-NT$120,147,000.0037.9x-320.4x12.6x
Wed, 27 Oct 2021NT$29.4bNT$2.8b-NT$511,386,000.0023.4x-57.4x10.4x
Fri, 24 Sep 2021NT$36.2bNT$2.3b-NT$631,150,000.0031.8x-57.3x15.6x
Sun, 22 Aug 2021NT$36.7bNT$2.3b-NT$631,150,000.0032x-58.2x15.8x
Fri, 09 Jul 2021NT$41.2bNT$2.3b-NT$631,150,000.0033x-65.3x17.7x
Thu, 01 Apr 2021NT$27.9bNT$2.2b-NT$810,177,000.0029x-34.4x12.9x
Sun, 03 Jan 2021NT$14.9bNT$2.2b-NT$912,568,000.0025.2x-16.3x6.7x
Wed, 07 Oct 2020NT$19.2bNT$2.1b-NT$914,668,000.0021.9x-21x9x
Tue, 30 Jun 2020NT$19.5bNT$1.8b-NT$1,161,248,000.0020.7x-16.8x10.7x
Fri, 03 Apr 2020NT$8.0bNT$1.8b-NT$951,923,500.0018.3x-8.4x4.4x
Price to Earnings Ratio

-9.5x


Total Market Cap: NT$7.3bTotal Earnings: -NT$771,818,000.00Total Revenue: NT$1.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Life Sciences Industry Price to Earnings3Y Average 6.3x202120222023
Current Industry PE
  • Investors are optimistic on the Taiwanese Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 531x which is higher than its 3-year average PE of 4.9x.
  • The 3-year average PS ratio of 11.6x is lower than the industry's current PS ratio of 16.9x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market2.33%
Healthcare3.71%
Life Sciences9.82%
Clinical Research and Equipment9.82%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6589 EirGenixNT$117.007.3%
+NT$2.4b
16.4%PS24x
6891 Locus CellNT$46.3530.7%
+NT$2.2b
n/aPB4.8x
4133 Abnova (Taiwan)NT$38.601.6%
+NT$36.3m
-18.1%PE37.9x
6661 Welgene BiotechLtdNT$22.802.2%
+NT$11.7m
4.1%PE20.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6589

NT$117.00

EirGenix

7D

7.3%

1Y

16.4%

6848

NT$14.20

RBC Bioscience

7D

-1.4%

1Y

-60.8%

4133

NT$38.60

Abnova (Taiwan)

7D

1.6%

1Y

-18.1%

6662

NT$30.00

BioLASCO Taiwan

7D

-0.3%

1Y

0%

6661

NT$22.80

Welgene BiotechLtd

7D

2.2%

1Y

4.1%